NF1 Sequencing & Del/Dup
New York
Approved
Genes
Conditions
- Neurofibromatosis Type 1
Clinical Utility
- Establish or confirm a clinical diagnosis Identification of at-risk family members
- Development of an appropriate evaluation and management
Lab Method
- MLPA
- Next-Gen Sequencing
Test Code
J660
CPT Codes*
81408x1
ABN Required
No
Turnaround Time**
3 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing